Hope on the horizon: Experimental antibiotic to treat deadly MRSA
from By Dorothy L. Tengler
Methicillin-resistant Staphylococcus aureus infection — better known as MRSA — is caused by a type of staph bacteria that has become resistant to many of the antibiotics used to treat ordinary staph infections. Thus, treating this potentially deadly infection has been a challenge for healthcare professionals. But a new experimental antibiotic developed by a team of scientists at Rutgers University has successfully treated MRSA in animal models.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063